Jan C. den Hollander

Jan C. den Hollander is a Researcher at Erasmus University Medical Center in the Pathology department, with a strong focus on HIV and related infectious diseases research. His work is primarily conducted through the ATHENA Observational HIV Cohort and other large-scale collaborative studies in the Netherlands.

Dr. den Hollander's research interests span HIV treatment optimization, antiretroviral therapy effectiveness, hepatitis B and C infections in immunocompromised patients, and metabolic considerations for people living with HIV. His fingerprint analysis shows significant contributions to Human Immunodeficiency Virus research (100%), HIV pharmacology (100%), Antiretroviral Therapy (44%), Lamivudine (37%), Rituximab (33%), Infection (33%), Hepatitis B (33%), and Cohort Analysis (33%).

His recent publications demonstrate a strong focus on real-world clinical applications of antiretroviral therapies, with particular attention to treatment switching strategies, long-term safety profiles of newer agents, and special population considerations including patients requiring immunosuppressive therapy or bariatric surgery.

Dr. den Hollander actively collaborates with numerous researchers across the Netherlands and participates in major HIV research initiatives, contributing to the field through high-impact publications in journals such as Open Forum Infectious Diseases, The Lancet HIV, and Clinical Infectious Diseases.